A top official has left the the Justice Department’s (DOJ) Antitrust Division just as it gears up for a trial over the merger of AT&T and Time Warner.
Director of Litigation Eric Mahr closed his two-year, two-month tenure at the DOJ last week, he confirmed Tuesday, November 22. Mahr, a former antitrust partner at Wilmer Cutler Pickering Hale and Dorr, said he always planned to only stay at the DOJ for a couple of years, and that his departure is not a result of changes at the department. His predecessor, Mayer Brown’s Mark Ryan, held it for a similar stretch between 2012 to 2015.
Asked why he didn’t depart during the change of administration, a common time for career lawyers to leave, Mahr said it was important for him to help ensure a smooth transition.
“I wanted to make sure I stayed as long as I could to help the transition of the new group and finish up the litigation that was filed under the previous administration,” he said.
Mahr is the second big-law attorney to hold the Director of Litigation position, with Ryan being the first. In addition to collaborating with other directors in the division, such as the directors of civil and criminal enforcement, the Director of Litigation is charged with training and developing litigation staff lawyers, as well as taking lead roles in trials and hearings, and providing strategic guidance. The role is currently listed as vacant on the division’s website.
Full Content: Law
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan